Corticosteroid Against Saline Injections for Thumb Osteoarthritis (CASITOA)

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversité du Québec à Trois-Rivières

About this trial

Thumb osteoarthritis or trapeziometacarpal osteoarthritis (TMO) is a common and painful form of hand arthritis that limits thumb mobility and hand function, affecting patients' quality of life. Although corticosteroids injections are a typical treatment, their effectiveness has been challenged, and side effects have been reported. Recent studies suggest that saline injections, usually considered inactive, might be a viable treatment option. The primary goal of this study is to compare the effectiveness of saline injections versus corticosteroids injections in reducing TMO-related pain and improving hand function. In this study, 40 people with TMO will be randomly assigned to receive either a corticosteroids or a saline injection, without them or the doctors performing the injection knowing which one was administered (double blind). If saline injections prove more effective, they could provide a less harmful and cheaper therapeutic alternative for TMO patients.

Eligibility criteria

Qualifiers

aged ≥18 years;

diagnosis of TMO was confirmed by X-ray interpreted by a radiologist;

suffering from pain at the base of the thumb;

the attending physician deems that an intra-articular corticosteroid injection would be beneficial, rather than opting for other types of intervention such as surgery

Disqualifiers

having received one or more corticosteroid injections in the last 12 months or surgery on the affected thumb;

suffering from painful thumb caused by a trauma (e.g., fracture, sprain), rheumatoid arthritis, or De Quervain's tendonitis; and

being pregnant or breastfeeding; and

known allergies to any components of the solutions (triamcinolone acetonide, benzyl alcohol, carboxymethylcellulose sodium, hydrochloric acid, polysorbate, sodium chloride, or sodium hydroxide) or to iodinated contrast media.

Trial design

Treatments tested in this trial

  • Saline Solution (NaCl 0,9%)
  • Triamcinolone Acetonide

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Université du Québec à Trois-Rivières

Lead sponsor

Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal

Collaborator

McGill University

Collaborator

Université de Montréal

Collaborator

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborator

Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Collaborator